MedTech Acquisition Corporation Unit
MTACU
MTACU was delisted on the 10th of August, 2023.
31 hedge funds and large institutions have $102M invested in MedTech Acquisition Corporation Unit in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 37 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less funds holding
Funds holding: 62 → 31 (-31)
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
58% less capital invested
Capital invested by funds: $245M → $102M (-$143M)
84% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
Diameter Capital Partners
New York
|
+$7.57M |
| 2 |
HP
Hartree Partners
New York
|
+$2.81M |
| 3 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
+$2.13M |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$1.58M |
| 5 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
+$1.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$28.9M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$13.1M |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$12.2M |
| 4 |
LA
Linden Advisors
New York
|
-$7.88M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$7.09M |
MTACU Hedge Fund Activity: Q1 2021 in Review
31 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q1 2021, worth a combined $102M — down 58% from $245M a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of MTACU and 6 opened new positions — a net loss of 31 holders — while 14 trimmed existing stakes and 6 added.
The largest buyer was Diameter Capital Partners, opening a new position worth an estimated $7.57M. The largest seller was BlackRock, exiting entirely with an estimated $28.9M sold.
- 31 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q1 2021, down from 62 in Q4 2020.
- Funds reported $102M of MedTech Acquisition Corporation Unit stock for Q1 2021, down 58% quarter-over-quarter.
- 6 funds opened new MedTech Acquisition Corporation Unit positions in Q1 2021 and 37 closed out, a net change of -31 holders.
- The largest MedTech Acquisition Corporation Unit buyer in Q1 2021 was Diameter Capital Partners, an estimated $7.57M added.
- The largest MedTech Acquisition Corporation Unit seller in Q1 2021 was BlackRock, an estimated $28.9M sold.
Based on aggregated 13F filings for Q1 2021.